Cathay Biotech Inc.

688065

CNE100004447

Specialty Chemicals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
49.16 ^CNY	+12.99%		+22.53%	-10.59%

Apr. 15	Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	MT
Apr. 02	Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	CI

Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.

October 09, 2023

From August 17, 2023 to September 30, 2023, the company has repurchased 455,236 shares, representing 0.08% for CNY 25.57 million. With this, the company has completed the repurchase of 455,236 shares, representing 0.08% for CNY 25.57 million under the buyback announced on August 17, 2023.

Latest news about Cathay Biotech Inc.

Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	Apr. 15	MT
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	Apr. 01	CI
Cathay Biotech's 2023 Profit Drops 34% as Revenue Falls 13%	Feb. 25	MT
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Cathay Biotech Inc. and 3P.Com Co. Limited Signs Joint Venture Agreement to Propel Sustainable Composite Innovations	Feb. 08	CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	Jan. 02	CI
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	23-10-09	CI
Cathay Biotech Inc.(XSSC:688065) added to S&P Global BMI Index	23-09-18	CI
Cathay Biotech Inc.(XSSC:688065) added to FTSE All-World Index	23-09-18	CI
Cathay Biotech Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	23-08-17	CI
Cathay Biotech Inc. authorizes a Buyback Plan.	23-08-16	CI
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-03	CI
Cathay Biotech Forms Business Cooperation Agreement	23-06-27	MT
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Cathay Biotech Inc. announced that it expects to receive CNY 6.599999958 billion in funding	23-06-24	CI
Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
MoleculeMind announced that it has received CNY 100 million in funding from Lenovo Capital and Incubator Group, Sequoia China Investment Management LLP, Cathay Biotech Inc.	23-02-19	CI
Cathay Biotech CFO Resigns	23-01-10	MT
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on March 30, 2022.	22-11-30	CI
Cathay Biotech Inc.'s Equity Buyback announced on March 30, 2022, has expired with 1,133,035 shares, representing 0.19% for CNY 94.57 million.	22-11-29	CI
Cathay Biotech Inc. announced that it has received $28 million in funding from Eight Roads Ventures, Sequoia China Investment Management LLP, Source Code Capital, Bits x Bites	22-11-06	CI
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
HBM Healthcare Swings To Fiscal H1 Loss On Reduced Share Price Of Portfolio Company Cathay Biotech	22-10-21	MT

Chart Cathay Biotech Inc.

Duration

Period

More charts

Company Profile

Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.

Sector

Specialty Chemicals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
CATHAY BIOTECH INC.	-10.59%	3.5B
NOVONESIS A/S	+5.01%	25.92B
BORREGAARD ASA	+11.55%	1.7B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-18.40%	563M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-21.41%	384M
BIO-ON S.P.A.	-81.65%	216M
CHEMCON SPECIALITY CHEMICALS LIMITED	-11.15%	114M

Industrial Biotechnology Chemicals

Cathay Biotech Inc.

Equities

688065

CNE100004447

Specialty Chemicals

Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.

Latest news about Cathay Biotech Inc.

Chart Cathay Biotech Inc.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Industrial Biotechnology Chemicals